Stephens & Co. analyst Trey Grooms maintains Builders FirstSource (NYSE:BLDR) with a Overweight and raises the price target from $75 to $90.
Wells Fargo Maintains Overweight on Karuna Therapeutics, Raises Price Target to $137
Wells Fargo maintains Karuna Therapeutics (NASDAQ:KRTX) with a Overweight and raises the price target from $106 to $137.